Companion Animal Diagnostics Market to Observe Strong Development by 2027

Transparency Market Research (TMR) has published a new report on the companion animal diagnostics market for the forecast period of 2019–2027. According to the report, the global companion animal diagnostics market was valued at ~US$ 2.3 Bn in 2018 and is projected to expand at a CAGR of ~9% from 2019 to 2027.

Global Companion Animal Diagnostics Market: Overview

• Expansion of the global companion animal diagnostics market can be attributed to a rise in the incidence of obesity and other diseases in companion animals and increasing pet ownership.
• North America dominated the global companion animal diagnostics market in 2018, and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early new product adoption, and presence of major market players are expected to drive the market in North America.
• Asia Pacific is expected to be a highly lucrative market for companion animal diagnostics, expanding at a high CAGR during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66719

Clinical biochemistry to Dominate Companion Animal Diagnostics Market

• The clinical biochemistry segment dominated the global companion animal diagnostics market in 2018, and the trend is likely to continue during the forecast period. Clinical biochemistry tests refer to blood tests or lab tests that help gain information about the health of the companion animal. Clinical biochemistry also includes glucose analysis, electrolyte analysis and others. Increasing demand and popularity of chemistry analyzers and glucose monitoring devices in disease diagnosis drives the segment. Moreover, the high preference for various advanced clinical diagnostic products by veterinarians, pet owners, and laboratory technicians is likely to fuel the clinical biochemistry segment in the next few years.

Companion Animal Diagnostics Market: Clinical Pathology to Offer Lucrative Opportunities

• In terms of application, the global companion animal diagnostics market is divided into clinical pathology, bacteriology, parasitology, and others.
• The clinical pathology segment includes cytopathology, hematology, clinical chemistry, immunohematology, coagulation, urinalysis, endocrinology, and general pathology. The clinical pathology segment dominated the global companion animal diagnostics market due to a rise in the demand for diagnostic products and consumables needed to be used during pathology testing, and an increase the number of pathology tests performed on pets.
• Bacteriology is estimated to be a highly lucrative segment of the companion animal diagnostics market during the forecast period. Bacteriology refers to the diagnosis of various bacterial diseases and infection in companion animals. Bacteriology tests include bacterial pathogens testing in blood or serum samples, and aerobic and anaerobic culture testing.

Request for Analysis of COVID-19 Impact on Companion Animal Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=66719

Veterinary Reference Laboratories Account for Major Market Share

• The veterinary reference laboratories segment dominated the global companion animal diagnostics market, in terms of revenue, in 2018. The trend is projected to continue during the forecast period. Increase in the number of veterinary reference laboratories across globe and availability of new advanced tests are likely to propel the segment. Furthermore, veterinary reference laboratories provide veterinary diagnostics to pet owners, and government-related programs or research collaborations are likely to boost the veterinary reference laboratories segment in the companion animal diagnostics market during the forecast period.
• Veterinary hospitals and clinics is projected to be the second-most lucrative segment of the global companion animal diagnostics market during the forecast period. The segment is expected to expand at a significant CAGR from 2019 to 2027, as veterinary hospitals and clinics provide diverse veterinary diagnostic services for companion animals, and also provide advanced diagnosis testing.

North America to Dominate Global Companion Animal Diagnostics Market

• North America accounted for a major share of the global companion animal diagnostics market in 2018, owing to an increase in pet ownership, pet insurance, and presence of major manufacturers in the region. According to North American Pet Health Insurance Association (NAPHIA) reports, the total number of pets insured in the U.S. and Canada reached 2.43 million at year-end 2018, an increase of 17% from 2017.
• The companion animal diagnostics market in Asia Pacific is likely to expand at a high CAGR from 2019 to 2027. This can be attributed to an increase in the number of companion animals in countries such as China and Japan, improvement of healthcare infrastructure in terms of better facilities, and a rise in the demand for advanced products in the region.

Buy Companion Animal Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=66719&ltype=S

Global Companion Animal Diagnostics Market: Competitive Landscape

The global companion animal diagnostics market is fragmented in terms of number of players. Key players operating in the global companion animal diagnostics market include Heska Corporation, IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Zoetis, Inc., Neogen Corporation, bioMérieux SA, Randox Laboratories Ltd., and Virbac.

Browse more Reports by Transparency Market Research:

Hemoglobin A1c Testing Devices Market: The global hemoglobin A1c testing market for the historical year of 2017 and forecast period of 2019 to 2027, increase in the demand for point-of-care testing for the diagnosis of diabetes, high prevalence of diabetes, and launch of automated hemoglobin A1c testing analyzers are expected to boost the growth of the global hemoglobin A1c testing market during the forecast period.

Drug Eluting Balloon Market: The global drug eluting balloon market is characterized by increase in incidence of peripheral artery diseases (PAD) across the world. The market is witnessing gradual rise in research and development activities supported by government policies. The global drug eluting balloon market was valued at US$ 420 Mn in 2017 and is projected to reach US$ 1800 Mn in 2026, expanding at a CAGR of 18% from 2018 to 2026.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/